Radiation boosts breast cancer drug lifespan in new trial

NCT ID NCT06925984

Recruiting now Disease control Sponsor: Jules Bordet Institute Source: ClinicalTrials.gov ↗

First seen Jan 11, 2026 · Last updated May 15, 2026 · Updated 16 times

Summary

This study is for women with ER+/HER2- breast cancer that has spread and is starting to grow again in 1 to 3 spots while on hormone therapy. Doctors will use precise radiation on those growing spots while continuing the same pills. The goal is to see if this approach can delay the need to switch to a different treatment, keeping a well-tolerated therapy effective for longer.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

AZ Groeninge
RECRUITING

Kortrijk, Belgium

Contact Phone: •••-•••-•••• Email: •••••@•••••
AZ Sint-Maarten
RECRUITING

Mechelen, Belgium

Contact Phone: •••-•••-•••• Email: •••••@•••••
CHU UCL Namur - Site Saint Elisabeth
RECRUITING

Namur, Belgium

Contact Phone: •••-•••-•••• Email: •••••@•••••
Jules Bordet Institute
RECRUITING

Brussels, Belgium

Contact Phone: •••-•••-•••• Email: •••••@•••••
UZ Gent
RECRUITING

Ghent, Belgium

Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.

OLIGOPROGRESSIVE METASTATIC DISEASE